RIO DE JANEIRO, BRAZIL - The Butantan Institute announced on Friday, March 26th, its first domestically manufactured vaccine, Butanvac, developed by the São Paulo state-owned entity, which is awaiting authorization from regulatory bodies to begin immediate testing in humans, according to the governor of São Paulo, João Doria.
"This is a historic announcement for the world. The vaccine is one hundred percent domestic, with promising tests and the result of the work of a 120-year-old institution, which is the largest producer of vaccines in the Southern Hemisphere," said Doria at a press conference at the . . .